AAAAAA

   
Results: 1-25 | 26-41
Results: 1-25/41
Comparative antiplatelet efficacy of a novel, nonpeptide GPIIb/IIIa antagonist (XV454) and abciximab (c7E3) in flow models of thrombosis
Authors: Abulencia, JP Tien, N McCarty, OJT Plymire, D Mousa, SA Konstantopoulos, K
Citation: Jp. Abulencia et al., Comparative antiplatelet efficacy of a novel, nonpeptide GPIIb/IIIa antagonist (XV454) and abciximab (c7E3) in flow models of thrombosis, ART THROM V, 21(1), 2001, pp. 149-156
Synthesis and pharmacology of modified amidine isoxazoline glycoprotein IIb/IIIa receptor antagonists
Authors: Sielecki, TM Liu, J Mousa, SA Racanelli, AL Hausner, EA Wexler, RR Olson, RE
Citation: Tm. Sielecki et al., Synthesis and pharmacology of modified amidine isoxazoline glycoprotein IIb/IIIa receptor antagonists, BIOORG MED, 11(16), 2001, pp. 2201-2204
Integrin-binding peptides containing RGD produce coronary arteriolar dilation via cyclooxygenase activation
Authors: Hein, TW Platts, SH Waitkus-Edwards, KR Kuo, L Mousa, SA Meininger, GA
Citation: Tw. Hein et al., Integrin-binding peptides containing RGD produce coronary arteriolar dilation via cyclooxygenase activation, AM J P-HEAR, 281(6), 2001, pp. H2378-H2384
Effects in humans of intravenously administered endotoxin on soluble cell-adhesion molecule and inflammatory markers: A model of human diseases
Authors: Wilson, MF Blum, R Dandona, P Mousa, SA
Citation: Mf. Wilson et al., Effects in humans of intravenously administered endotoxin on soluble cell-adhesion molecule and inflammatory markers: A model of human diseases, CLIN EXP PH, 28(5-6), 2001, pp. 376-380
beta-endorphin-containing memory-cells and mu-opioid receptors undergo transport to peripheral inflamed tissue
Authors: Mousa, SA Zhang, Q Sitte, N Ji, RR Stein, C
Citation: Sa. Mousa et al., beta-endorphin-containing memory-cells and mu-opioid receptors undergo transport to peripheral inflamed tissue, J NEUROIMM, 115(1-2), 2001, pp. 71-78
Comparison of the effect of different platelet GPIIb/IIa antagonists on the dynamics of platelet/fibrin-mediated clot strength induced using thromboelastography
Authors: Mousa, SA Forsythe, MS
Citation: Sa. Mousa et Ms. Forsythe, Comparison of the effect of different platelet GPIIb/IIa antagonists on the dynamics of platelet/fibrin-mediated clot strength induced using thromboelastography, THROMB RES, 104(1), 2001, pp. 49-56
Selective alpha(v)beta(3)-receptor blockade reduces macrophage infiltration and restenosis after balloon angioplasty in the atherosclerotic rabbit
Authors: Bishop, GG McPherson, JA Sanders, JM Hesselbacher, SE Feldman, MJ McNamara, CA Gimple, LW Powers, ER Mousa, SA Sarembock, IJ
Citation: Gg. Bishop et al., Selective alpha(v)beta(3)-receptor blockade reduces macrophage infiltration and restenosis after balloon angioplasty in the atherosclerotic rabbit, CIRCULATION, 103(14), 2001, pp. 1906-1911
Platelet GPIIb/IIIa binding characteristics of small molecule RGD mimetic:distinct binding profile for Roxifiban
Authors: Mousa, SA Bozarth, JM Naik, UP Slee, A
Citation: Sa. Mousa et al., Platelet GPIIb/IIIa binding characteristics of small molecule RGD mimetic:distinct binding profile for Roxifiban, BR J PHARM, 133(3), 2001, pp. 331-336
Opioid peptide-expressing leukocytes - Identification, recruitment, and simultaneously increasing inhibition of inflammatory pain
Authors: Rittner, HL Brack, A Machelska, H Mousa, SA Bauer, M Schafer, M Stein, C
Citation: Hl. Rittner et al., Opioid peptide-expressing leukocytes - Identification, recruitment, and simultaneously increasing inhibition of inflammatory pain, ANESTHESIOL, 95(2), 2001, pp. 500-508
Small molecule alpha(v) integrin antagonists: novel anticancer agents
Authors: Kerr, JS Slee, AM Mousa, SA
Citation: Js. Kerr et al., Small molecule alpha(v) integrin antagonists: novel anticancer agents, EXPERT OP I, 9(6), 2000, pp. 1271-1279
Potential role of platelet glycoprotein IIb/IIIa antagonists in cerebrovascular disorders
Authors: Mousa, SA
Citation: Sa. Mousa, Potential role of platelet glycoprotein IIb/IIIa antagonists in cerebrovascular disorders, CNS DRUGS, 13(3), 2000, pp. 155-160
Comparative in vitro efficacy of different platelet glycoprotein IIb/IIIa antagonists on platelet-mediated clot strength induced by tissue factor with use of thromboelastography - Differentiation among glycoprotein IIb/IIIa antagonists
Authors: Mousa, SA Khurana, S Forsythe, MS
Citation: Sa. Mousa et al., Comparative in vitro efficacy of different platelet glycoprotein IIb/IIIa antagonists on platelet-mediated clot strength induced by tissue factor with use of thromboelastography - Differentiation among glycoprotein IIb/IIIa antagonists, ART THROM V, 20(4), 2000, pp. 1162-1167
Template-constrained cyclic peptide analogues of somatostatin: Subtype-selective binding to somatostatin receptors and antiangiogenic activity
Authors: Suich, DJ Mousa, SA Singh, G Liapakis, G Reisine, T DeGrado, WF
Citation: Dj. Suich et al., Template-constrained cyclic peptide analogues of somatostatin: Subtype-selective binding to somatostatin receptors and antiangiogenic activity, BIO MED CH, 8(9), 2000, pp. 2229-2241
Ring constrained analogues of beta-alanine-containing GPIIb/IIIa receptor antagonists
Authors: Sielecki, TM Wityak, J Liu, J Mousa, SA Thoolen, M Wexler, RR Olson, RE
Citation: Tm. Sielecki et al., Ring constrained analogues of beta-alanine-containing GPIIb/IIIa receptor antagonists, BIOORG MED, 10(5), 2000, pp. 449-452
Human platelet alpha IIb beta 3 integrin binding affinity end specificity of SJ874: antiplatelet efficacy versus aspirin
Authors: Mousa, SA Forsythe, M Bozarth, J Jin, FQ Confalone, PN
Citation: Sa. Mousa et al., Human platelet alpha IIb beta 3 integrin binding affinity end specificity of SJ874: antiplatelet efficacy versus aspirin, CORON ART D, 11(7), 2000, pp. 563-570
Antiangiogenesis efficacy of nitric oxide donors
Authors: Powell, JA Mohamed, SN Kerr, JS Mousa, SA
Citation: Ja. Powell et al., Antiangiogenesis efficacy of nitric oxide donors, J CELL BIOC, 80(1), 2000, pp. 104-114
Hypoxia induces differential expression of the integrin receptors alpha(v beta 3) and alpha(v beta 5) cultured human endothelial cells
Authors: Walton, HL Corjay, MH Mohamed, SN Mousa, SA Santomenna, LD Reilly, TM
Citation: Hl. Walton et al., Hypoxia induces differential expression of the integrin receptors alpha(v beta 3) and alpha(v beta 5) cultured human endothelial cells, J CELL BIOC, 78(4), 2000, pp. 674-680
Immunocytochemical studies of the gonadotropic cells in the pituitary gland of male mullet, Mugil cephalus, during the annual reproductive cycle in both natural habitat and captivity
Authors: Mousa, MA Mousa, SA
Citation: Ma. Mousa et Sa. Mousa, Immunocytochemical studies of the gonadotropic cells in the pituitary gland of male mullet, Mugil cephalus, during the annual reproductive cycle in both natural habitat and captivity, J APP ICHTH, 16(3), 2000, pp. 98-103
Co-expression of beta-endorphin with adhesion molecules in a model of inflammatory pain
Authors: Mousa, SA Machelska, H Schafer, M Stein, C
Citation: Sa. Mousa et al., Co-expression of beta-endorphin with adhesion molecules in a model of inflammatory pain, J NEUROIMM, 108(1-2), 2000, pp. 160-170
Comparative efficacy of different low-molecular-weight heparins (LMWHs) and drug interactions with LMWH: Implications for management of vascular disorders
Authors: Mousa, SA
Citation: Sa. Mousa, Comparative efficacy of different low-molecular-weight heparins (LMWHs) and drug interactions with LMWH: Implications for management of vascular disorders, SEM THROMB, 26, 2000, pp. 39-46
A nonpeptide integrin antagonist can inhibit epithelial cell ingestion of Streptococcus pyogenes by blocking formation of integrin alpha 5 beta 1-fibronectin-M1 protein complexes
Authors: Cue, D Southern, SO Southern, PJ Prabhakar, J Lorelli, W Smallheer, JM Mousa, SA Cleary, PP
Citation: D. Cue et al., A nonpeptide integrin antagonist can inhibit epithelial cell ingestion of Streptococcus pyogenes by blocking formation of integrin alpha 5 beta 1-fibronectin-M1 protein complexes, P NAS US, 97(6), 2000, pp. 2858-2863
Isoxazolines as potent antagonists of the integrin alpha(v)beta(3)
Authors: Pitts, WJ Wityak, J Smallheer, JM Tobin, AE Jetter, JW Buynitsky, JS Harlow, PP Solomon, KA Corjay, MH Mousa, SA Wexler, RR Jadhav, PK
Citation: Wj. Pitts et al., Isoxazolines as potent antagonists of the integrin alpha(v)beta(3), J MED CHEM, 43(1), 2000, pp. 27-40
Disubstituted indazoles as potent antagonists of the integrin alpha(v)beta(3)
Authors: Batt, DG Petraitis, JJ Houghton, GC Modi, DP Cain, GA Corjay, MH Mousa, SA Bouchard, PJ Forsythe, MS Harlow, PP Barbera, FA Spitz, SM Wexler, RR Jadhav, PK
Citation: Dg. Batt et al., Disubstituted indazoles as potent antagonists of the integrin alpha(v)beta(3), J MED CHEM, 43(1), 2000, pp. 41-58
Implication of somatolactin in the regulation of sexual maturation and spawning of Mugil cephalus
Authors: Mousa, MA Mousa, SA
Citation: Ma. Mousa et Sa. Mousa, Implication of somatolactin in the regulation of sexual maturation and spawning of Mugil cephalus, J EXP ZOOL, 287(1), 2000, pp. 62-73
Differential antiplatelet efficacy for various GPIIb/IIIa antagonists: Role of plasma calcium levels
Authors: Mousa, SA Bozarth, JM Forsythe, MS Slee, A
Citation: Sa. Mousa et al., Differential antiplatelet efficacy for various GPIIb/IIIa antagonists: Role of plasma calcium levels, CARDIO RES, 47(4), 2000, pp. 819-826
Risultati: 1-25 | 26-41